New York, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Respiratory Diagnostics Industry" - https://www.reportlinker.com/p05799512/?utm_source=GNW
5 Billion by 2027, growing at a CAGR of 6.1% over the analysis period 2020-2027. Tuberculosis, one of the segments analyzed in the report, is projected to record a 5.9% CAGR and reach US$3.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Asthma segment is readjusted to a revised 6.1% CAGR for the next 7-year period.
The U.S. Market is Estimated at $1.7 Billion, While China is Forecast to Grow at 9.3% CAGR
The Respiratory Diagnostics market in the U.S. is estimated at US$1.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2 Billion by the year 2027 trailing a CAGR of 9.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.3% and 5.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.
Chronic Obstructive Pulmonary Disease Segment to Record 6.9% CAGR
In the global Chronic Obstructive Pulmonary Disease segment, USA, Canada, Japan, China and Europe will drive the 6.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$949.1 Million in the year 2020 will reach a projected size of US$1.5 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.3 Billion by the year 2027, while Latin America will expand at a 8.2% CAGR through the analysis period. We bring years of research experience to this 6th edition of our report. The 286-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others,
- Abbott Laboratories
- Alere, Inc.
- Becton, Dickinson and Company
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- Cosmed Srl
- Philips Healthcare
- SDI Diagnostics
- Seegene, Inc.
- Thermo Fisher Scientific, Inc.
Read the full report: https://www.reportlinker.com/p05799512/?utm_source=GNW
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Respiratory Diagnostics Competitor Market Share Scenario
Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Respiratory Diagnostics Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2020-2027
Table 2: Respiratory Diagnostics Global Retrospective Market
Scenario in US$ Million by Region/Country: 2012-2019
Table 3: Respiratory Diagnostics Market Share Shift across Key
Geographies Worldwide: 2012 VS 2020 VS 2027
Table 4: Tuberculosis (Disease) World Market by Region/Country
in US$ Million: 2020 to 2027
Table 5: Tuberculosis (Disease) Historic Market Analysis by
Region/Country in US$ Million: 2012 to 2019
Table 6: Tuberculosis (Disease) Market Share Breakdown of
Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
Table 7: Asthma (Disease) Potential Growth Markets Worldwide in
US$ Million: 2020 to 2027
Table 8: Asthma (Disease) Historic Market Perspective by
Region/Country in US$ Million: 2012 to 2019
Table 9: Asthma (Disease) Market Sales Breakdown by
Region/Country in Percentage: 2012 VS 2020 VS 2027
Table 10: Chronic Obstructive Pulmonary Disease (Disease)
Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
Table 11: Chronic Obstructive Pulmonary Disease (Disease)
Region Wise Breakdown of Global Historic Demand in US$ Million:
2012 to 2019
Table 12: Chronic Obstructive Pulmonary Disease (Disease)
Market Share Distribution in Percentage by Region/Country: 2012
VS 2020 VS 2027
Table 13: Other Diseases (Disease) World Market Estimates and
Forecasts by Region/Country in US$ Million: 2020 to 2027
Table 14: Other Diseases (Disease) Market Historic Review by
Region/Country in US$ Million: 2012 to 2019
Table 15: Other Diseases (Disease) Market Share Breakdown by
Region/Country: 2012 VS 2020 VS 2027
Table 16: Hospital/Clinical Laboratories (End-Use) Worldwide
Latent Demand Forecasts in US$ Million by Region/Country:
2020-2027
Table 17: Hospital/Clinical Laboratories (End-Use) Global
Historic Analysis in US$ Million by Region/Country: 2012-2019
Table 18: Hospital/Clinical Laboratories (End-Use) Distribution
of Global Sales by Region/Country: 2012 VS 2020 VS 2027
Table 19: Physician Offices (End-Use) Sales Estimates and
Forecasts in US$ Million by Region/Country for the Years 2020
through 2027
Table 20: Physician Offices (End-Use) Analysis of Historic
Sales in US$ Million by Region/Country for the Years 2012 to
2019
Table 21: Physician Offices (End-Use) Global Market Share
Distribution by Region/Country for 2012, 2020, and 2027
Table 22: Reference Laboratories (End-Use) Global Opportunity
Assessment in US$ Million by Region/Country: 2020-2027
Table 23: Reference Laboratories (End-Use) Historic Sales
Analysis in US$ Million by Region/Country: 2012-2019
Table 24: Reference Laboratories (End-Use) Percentage Share
Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS
2027
Table 25: Other End-Uses (End-Use) Worldwide Sales in US$
Million by Region/Country: 2020-2027
Table 26: Other End-Uses (End-Use) Historic Demand Patterns in
US$ Million by Region/Country: 2012-2019
Table 27: Other End-Uses (End-Use) Market Share Shift across
Key Geographies: 2012 VS 2020 VS 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Respiratory Diagnostics Market Share (in %) by Company: 2019 &
2025
Market Analytics
Table 28: United States Respiratory Diagnostics Market
Estimates and Projections in US$ Million by Disease: 2020 to
2027
Table 29: Respiratory Diagnostics Market in the United States
by Disease: A Historic Review in US$ Million for 2012-2019
Table 30: United States Respiratory Diagnostics Market Share
Breakdown by Disease: 2012 VS 2020 VS 2027
Table 31: United States Respiratory Diagnostics Latent Demand
Forecasts in US$ Million by End-Use: 2020 to 2027
Table 32: Respiratory Diagnostics Historic Demand Patterns in
the United States by End-Use in US$ Million for 2012-2019
Table 33: Respiratory Diagnostics Market Share Breakdown in the
United States by End-Use: 2012 VS 2020 VS 2027
CANADA
Table 34: Canadian Respiratory Diagnostics Market Estimates and
Forecasts in US$ Million by Disease: 2020 to 2027
Table 35: Canadian Respiratory Diagnostics Historic Market
Review by Disease in US$ Million: 2012-2019
Table 36: Respiratory Diagnostics Market in Canada: Percentage
Share Breakdown of Sales by Disease for 2012, 2020, and 2027
Table 37: Canadian Respiratory Diagnostics Market Quantitative
Demand Analysis in US$ Million by End-Use: 2020 to 2027
Table 38: Respiratory Diagnostics Market in Canada:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2012-2019
Table 39: Canadian Respiratory Diagnostics Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027
JAPAN
Table 40: Japanese Market for Respiratory Diagnostics: Annual
Sales Estimates and Projections in US$ Million by Disease for
the Period 2020-2027
Table 41: Respiratory Diagnostics Market in Japan: Historic
Sales Analysis in US$ Million by Disease for the Period
2012-2019
Table 42: Japanese Respiratory Diagnostics Market Share
Analysis by Disease: 2012 VS 2020 VS 2027
Table 43: Japanese Demand Estimates and Forecasts for
Respiratory Diagnostics in US$ Million by End-Use: 2020 to 2027
Table 44: Japanese Respiratory Diagnostics Market in US$
Million by End-Use: 2012-2019
Table 45: Respiratory Diagnostics Market Share Shift in Japan
by End-Use: 2012 VS 2020 VS 2027
CHINA
Table 46: Chinese Respiratory Diagnostics Market Growth
Prospects in US$ Million by Disease for the Period 2020-2027
Table 47: Respiratory Diagnostics Historic Market Analysis in
China in US$ Million by Disease: 2012-2019
Table 48: Chinese Respiratory Diagnostics Market by Disease:
Percentage Breakdown of Sales for 2012, 2020, and 2027
Table 49: Chinese Demand for Respiratory Diagnostics in US$
Million by End-Use: 2020 to 2027
Table 50: Respiratory Diagnostics Market Review in China in US$
Million by End-Use: 2012-2019
Table 51: Chinese Respiratory Diagnostics Market Share
Breakdown by End-Use: 2012 VS 2020 VS 2027
EUROPE
Market Facts & Figures
European Respiratory Diagnostics Market: Competitor Market
Share Scenario (in %) for 2019 & 2025
Market Analytics
Table 52: European Respiratory Diagnostics Market Demand
Scenario in US$ Million by Region/Country: 2020-2027
Table 53: Respiratory Diagnostics Market in Europe: A Historic
Market Perspective in US$ Million by Region/Country for the
Period 2012-2019
Table 54: European Respiratory Diagnostics Market Share Shift
by Region/Country: 2012 VS 2020 VS 2027
Table 55: European Respiratory Diagnostics Market Estimates and
Forecasts in US$ Million by Disease: 2020-2027
Table 56: Respiratory Diagnostics Market in Europe in US$
Million by Disease: A Historic Review for the Period 2012-2019
Table 57: European Respiratory Diagnostics Market Share
Breakdown by Disease: 2012 VS 2020 VS 2027
Table 58: European Respiratory Diagnostics Addressable Market
Opportunity in US$ Million by End-Use: 2020-2027
Table 59: Respiratory Diagnostics Market in Europe:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2012-2019
Table 60: European Respiratory Diagnostics Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027
FRANCE
Table 61: Respiratory Diagnostics Market in France by Disease:
Estimates and Projections in US$ Million for the Period
2020-2027
Table 62: French Respiratory Diagnostics Historic Market
Scenario in US$ Million by Disease: 2012-2019
Table 63: French Respiratory Diagnostics Market Share Analysis
by Disease: 2012 VS 2020 VS 2027
Table 64: Respiratory Diagnostics Quantitative Demand Analysis
in France in US$ Million by End-Use: 2020-2027
Table 65: French Respiratory Diagnostics Historic Market Review
in US$ Million by End-Use: 2012-2019
Table 66: French Respiratory Diagnostics Market Share Analysis:
A 17-Year Perspective by End-Use for 2012, 2020, and 2027
GERMANY
Table 67: Respiratory Diagnostics Market in Germany: Recent
Past, Current and Future Analysis in US$ Million by Disease for
the Period 2020-2027
Table 68: German Respiratory Diagnostics Historic Market
Analysis in US$ Million by Disease: 2012-2019
Table 69: German Respiratory Diagnostics Market Share Breakdown
by Disease: 2012 VS 2020 VS 2027
Table 70: Respiratory Diagnostics Market in Germany: Annual
Sales Estimates and Forecasts in US$ Million by End-Use for the
Period 2020-2027
Table 71: German Respiratory Diagnostics Market in Retrospect
in US$ Million by End-Use: 2012-2019
Table 72: Respiratory Diagnostics Market Share Distribution in
Germany by End-Use: 2012 VS 2020 VS 2027
ITALY
Table 73: Italian Respiratory Diagnostics Market Growth
Prospects in US$ Million by Disease for the Period 2020-2027
Table 74: Respiratory Diagnostics Historic Market Analysis in
Italy in US$ Million by Disease: 2012-2019
Table 75: Italian Respiratory Diagnostics Market by Disease:
Percentage Breakdown of Sales for 2012, 2020, and 2027
Table 76: Italian Demand for Respiratory Diagnostics in US$
Million by End-Use: 2020 to 2027
Table 77: Respiratory Diagnostics Market Review in Italy in US$
Million by End-Use: 2012-2019
Table 78: Italian Respiratory Diagnostics Market Share
Breakdown by End-Use: 2012 VS 2020 VS 2027
UNITED KINGDOM
Table 79: United Kingdom Market for Respiratory Diagnostics:
Annual Sales Estimates and Projections in US$ Million by
Disease for the Period 2020-2027
Table 80: Respiratory Diagnostics Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Disease for the
Period 2012-2019
Table 81: United Kingdom Respiratory Diagnostics Market Share
Analysis by Disease: 2012 VS 2020 VS 2027
Table 82: United Kingdom Demand Estimates and Forecasts for
Respiratory Diagnostics in US$ Million by End-Use: 2020 to 2027
Table 83: United Kingdom Respiratory Diagnostics Market in US$
Million by End-Use: 2012-2019
Table 84: Respiratory Diagnostics Market Share Shift in the
United Kingdom by End-Use: 2012 VS 2020 VS 2027
SPAIN
Table 85: Spanish Respiratory Diagnostics Market Estimates and
Forecasts in US$ Million by Disease: 2020 to 2027
Table 86: Spanish Respiratory Diagnostics Historic Market
Review by Disease in US$ Million: 2012-2019
Table 87: Respiratory Diagnostics Market in Spain: Percentage
Share Breakdown of Sales by Disease for 2012, 2020, and 2027
Table 88: Spanish Respiratory Diagnostics Market Quantitative
Demand Analysis in US$ Million by End-Use: 2020 to 2027
Table 89: Respiratory Diagnostics Market in Spain:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2012-2019
Table 90: Spanish Respiratory Diagnostics Market Share Analysis
by End-Use: 2012 VS 2020 VS 2027
RUSSIA
Table 91: Russian Respiratory Diagnostics Market Estimates and
Projections in US$ Million by Disease: 2020 to 2027
Table 92: Respiratory Diagnostics Market in Russia by Disease:
A Historic Review in US$ Million for 2012-2019
Table 93: Russian Respiratory Diagnostics Market Share
Breakdown by Disease: 2012 VS 2020 VS 2027
Table 94: Russian Respiratory Diagnostics Latent Demand
Forecasts in US$ Million by End-Use: 2020 to 2027
Table 95: Respiratory Diagnostics Historic Demand Patterns in
Russia by End-Use in US$ Million for 2012-2019
Table 96: Respiratory Diagnostics Market Share Breakdown in
Russia by End-Use: 2012 VS 2020 VS 2027
REST OF EUROPE
Table 97: Rest of Europe Respiratory Diagnostics Market
Estimates and Forecasts in US$ Million by Disease: 2020-2027
Table 98: Respiratory Diagnostics Market in Rest of Europe in
US$ Million by Disease: A Historic Review for the Period
2012-2019
Table 99: Rest of Europe Respiratory Diagnostics Market Share
Breakdown by Disease: 2012 VS 2020 VS 2027
Table 100: Rest of Europe Respiratory Diagnostics Addressable
Market Opportunity in US$ Million by End-Use: 2020-2027
Table 101: Respiratory Diagnostics Market in Rest of Europe:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2012-2019
Table 102: Rest of Europe Respiratory Diagnostics Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027
ASIA-PACIFIC
Table 103: Asia-Pacific Respiratory Diagnostics Market
Estimates and Forecasts in US$ Million by Region/Country:
2020-2027
Table 104: Respiratory Diagnostics Market in Asia-Pacific:
Historic Market Analysis in US$ Million by Region/Country for
the Period 2012-2019
Table 105: Asia-Pacific Respiratory Diagnostics Market Share
Analysis by Region/Country: 2012 VS 2020 VS 2027
Table 106: Respiratory Diagnostics Market in Asia-Pacific by
Disease: Estimates and Projections in US$ Million for the
Period 2020-2027
Table 107: Asia-Pacific Respiratory Diagnostics Historic Market
Scenario in US$ Million by Disease: 2012-2019
Table 108: Asia-Pacific Respiratory Diagnostics Market Share
Analysis by Disease: 2012 VS 2020 VS 2027
Table 109: Respiratory Diagnostics Quantitative Demand Analysis
in Asia-Pacific in US$ Million by End-Use: 2020-2027
Table 110: Asia-Pacific Respiratory Diagnostics Historic Market
Review in US$ Million by End-Use: 2012-2019
Table 111: Asia-Pacific Respiratory Diagnostics Market Share
Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and
2027
AUSTRALIA
Table 112: Respiratory Diagnostics Market in Australia: Recent
Past, Current and Future Analysis in US$ Million by Disease for
the Period 2020-2027
Table 113: Australian Respiratory Diagnostics Historic Market
Analysis in US$ Million by Disease: 2012-2019
Table 114: Australian Respiratory Diagnostics Market Share
Breakdown by Disease: 2012 VS 2020 VS 2027
Table 115: Respiratory Diagnostics Market in Australia: Annual
Sales Estimates and Forecasts in US$ Million by End-Use for the
Period 2020-2027
Table 116: Australian Respiratory Diagnostics Market in
Retrospect in US$ Million by End-Use: 2012-2019
Table 117: Respiratory Diagnostics Market Share Distribution in
Australia by End-Use: 2012 VS 2020 VS 2027
INDIA
Table 118: Indian Respiratory Diagnostics Market Estimates and
Forecasts in US$ Million by Disease: 2020 to 2027
Table 119: Indian Respiratory Diagnostics Historic Market
Review by Disease in US$ Million: 2012-2019
Table 120: Respiratory Diagnostics Market in India: Percentage
Share Breakdown of Sales by Disease for 2012, 2020, and 2027
Table 121: Indian Respiratory Diagnostics Market Quantitative
Demand Analysis in US$ Million by End-Use: 2020 to 2027
Table 122: Respiratory Diagnostics Market in India:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2012-2019
Table 123: Indian Respiratory Diagnostics Market Share Analysis
by End-Use: 2012 VS 2020 VS 2027
SOUTH KOREA
Table 124: Respiratory Diagnostics Market in South Korea:
Recent Past, Current and Future Analysis in US$ Million by
Disease for the Period 2020-2027
Table 125: South Korean Respiratory Diagnostics Historic Market
Analysis in US$ Million by Disease: 2012-2019
Table 126: Respiratory Diagnostics Market Share Distribution in
South Korea by Disease: 2012 VS 2020 VS 2027
Table 127: Respiratory Diagnostics Market in South Korea:
Recent Past, Current and Future Analysis in US$ Million by
End-Use for the Period 2020-2027
Table 128: South Korean Respiratory Diagnostics Historic Market
Analysis in US$ Million by End-Use: 2012-2019
Table 129: Respiratory Diagnostics Market Share Distribution in
South Korea by End-Use: 2012 VS 2020 VS 2027
REST OF ASIA-PACIFIC
Table 130: Rest of Asia-Pacific Market for Respiratory
Diagnostics: Annual Sales Estimates and Projections in US$
Million by Disease for the Period 2020-2027
Table 131: Respiratory Diagnostics Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Million by Disease
for the Period 2012-2019
Table 132: Rest of Asia-Pacific Respiratory Diagnostics Market
Share Analysis by Disease: 2012 VS 2020 VS 2027
Table 133: Rest of Asia-Pacific Demand Estimates and Forecasts
for Respiratory Diagnostics in US$ Million by End-Use: 2020 to
2027
Table 134: Rest of Asia-Pacific Respiratory Diagnostics Market
in US$ Million by End-Use: 2012-2019
Table 135: Respiratory Diagnostics Market Share Shift in Rest
of Asia-Pacific by End-Use: 2012 VS 2020 VS 2027
LATIN AMERICA
Table 136: Latin American Respiratory Diagnostics Market Trends
by Region/Country in US$ Million: 2020-2027
Table 137: Respiratory Diagnostics Market in Latin America in
US$ Million by Region/Country: A Historic Perspective for the
Period 2012-2019
Table 138: Latin American Respiratory Diagnostics Market
Percentage Breakdown of Sales by Region/Country: 2012, 2020,
and 2027
Table 139: Latin American Respiratory Diagnostics Market Growth
Prospects in US$ Million by Disease for the Period 2020-2027
Table 140: Respiratory Diagnostics Historic Market Analysis in
Latin America in US$ Million by Disease: 2012-2019
Table 141: Latin American Respiratory Diagnostics Market by
Disease: Percentage Breakdown of Sales for 2012, 2020, and 2027
Table 142: Latin American Demand for Respiratory Diagnostics in
US$ Million by End-Use: 2020 to 2027
Table 143: Respiratory Diagnostics Market Review in Latin
America in US$ Million by End-Use: 2012-2019
Table 144: Latin American Respiratory Diagnostics Market Share
Breakdown by End-Use: 2012 VS 2020 VS 2027
ARGENTINA
Table 145: Argentinean Respiratory Diagnostics Market Estimates
and Forecasts in US$ Million by Disease: 2020-2027
Table 146: Respiratory Diagnostics Market in Argentina in US$
Million by Disease: A Historic Review for the Period 2012-2019
Table 147: Argentinean Respiratory Diagnostics Market Share
Breakdown by Disease: 2012 VS 2020 VS 2027
Table 148: Argentinean Respiratory Diagnostics Addressable
Market Opportunity in US$ Million by End-Use: 2020-2027
Table 149: Respiratory Diagnostics Market in Argentina:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2012-2019
Table 150: Argentinean Respiratory Diagnostics Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027
BRAZIL
Table 151: Respiratory Diagnostics Market in Brazil by Disease:
Estimates and Projections in US$ Million for the Period
2020-2027
Table 152: Brazilian Respiratory Diagnostics Historic Market
Scenario in US$ Million by Disease: 2012-2019
Table 153: Brazilian Respiratory Diagnostics Market Share
Analysis by Disease: 2012 VS 2020 VS 2027
Table 154: Respiratory Diagnostics Quantitative Demand Analysis
in Brazil in US$ Million by End-Use: 2020-2027
Table 155: Brazilian Respiratory Diagnostics Historic Market
Review in US$ Million by End-Use: 2012-2019
Table 156: Brazilian Respiratory Diagnostics Market Share
Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and
2027
MEXICO
Table 157: Respiratory Diagnostics Market in Mexico: Recent
Past, Current and Future Analysis in US$ Million by Disease for
the Period 2020-2027
Table 158: Mexican Respiratory Diagnostics Historic Market
Analysis in US$ Million by Disease: 2012-2019
Table 159: Mexican Respiratory Diagnostics Market Share
Breakdown by Disease: 2012 VS 2020 VS 2027
Table 160: Respiratory Diagnostics Market in Mexico: Annual
Sales Estimates and Forecasts in US$ Million by End-Use for the
Period 2020-2027
Table 161: Mexican Respiratory Diagnostics Market in Retrospect
in US$ Million by End-Use: 2012-2019
Table 162: Respiratory Diagnostics Market Share Distribution in
Mexico by End-Use: 2012 VS 2020 VS 2027
REST OF LATIN AMERICA
Table 163: Rest of Latin America Respiratory Diagnostics Market
Estimates and Projections in US$ Million by Disease: 2020 to
2027
Table 164: Respiratory Diagnostics Market in Rest of Latin
America by Disease: A Historic Review in US$ Million for
2012-2019
Table 165: Rest of Latin America Respiratory Diagnostics Market
Share Breakdown by Disease: 2012 VS 2020 VS 2027
Table 166: Rest of Latin America Respiratory Diagnostics Latent
Demand Forecasts in US$ Million by End-Use: 2020 to 2027
Table 167: Respiratory Diagnostics Historic Demand Patterns in
Rest of Latin America by End-Use in US$ Million for 2012-2019
Table 168: Respiratory Diagnostics Market Share Breakdown in
Rest of Latin America by End-Use: 2012 VS 2020 VS 2027
MIDDLE EAST
Table 169: The Middle East Respiratory Diagnostics Market
Estimates and Forecasts in US$ Million by Region/Country:
2020-2027
Table 170: Respiratory Diagnostics Market in the Middle East by
Region/Country in US$ Million: 2012-2019
Table 171: The Middle East Respiratory Diagnostics Market Share
Breakdown by Region/Country: 2012, 2020, and 2027
Table 172: The Middle East Respiratory Diagnostics Market
Estimates and Forecasts in US$ Million by Disease: 2020 to 2027
Table 173: The Middle East Respiratory Diagnostics Historic
Market by Disease in US$ Million: 2012-2019
Table 174: Respiratory Diagnostics Market in the Middle East:
Percentage Share Breakdown of Sales by Disease for 2012,2020,
and 2027
Table 175: The Middle East Respiratory Diagnostics Market
Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
2027
Table 176: Respiratory Diagnostics Market in the Middle East:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2012-2019
Table 177: The Middle East Respiratory Diagnostics Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027
IRAN
Table 178: Iranian Market for Respiratory Diagnostics: Annual
Sales Estimates and Projections in US$ Million by Disease for
the Period 2020-2027
Table 179: Respiratory Diagnostics Market in Iran: Historic
Sales Analysis in US$ Million by Disease for the Period
2012-2019
Table 180: Iranian Respiratory Diagnostics Market Share
Analysis by Disease: 2012 VS 2020 VS 2027
Table 181: Iranian Demand Estimates and Forecasts for
Respiratory Diagnostics in US$ Million by End-Use: 2020 to 2027
Table 182: Iranian Respiratory Diagnostics Market in US$
Million by End-Use: 2012-2019
Table 183: Respiratory Diagnostics Market Share Shift in Iran
by End-Use: 2012 VS 2020 VS 2027
ISRAEL
Table 184: Israeli Respiratory Diagnostics Market Estimates and
Forecasts in US$ Million by Disease: 2020-2027
Table 185: Respiratory Diagnostics Market in Israel in US$
Million by Disease: A Historic Review for the Period 2012-2019
Table 186: Israeli Respiratory Diagnostics Market Share
Breakdown by Disease: 2012 VS 2020 VS 2027
Table 187: Israeli Respiratory Diagnostics Addressable Market
Opportunity in US$ Million by End-Use: 2020-2027
Table 188: Respiratory Diagnostics Market in Israel:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2012-2019
Table 189: Israeli Respiratory Diagnostics Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027
SAUDI ARABIA
Table 190: Saudi Arabian Respiratory Diagnostics Market Growth
Prospects in US$ Million by Disease for the Period 2020-2027
Table 191: Respiratory Diagnostics Historic Market Analysis in
Saudi Arabia in US$ Million by Disease: 2012-2019
Table 192: Saudi Arabian Respiratory Diagnostics Market by
Disease: Percentage Breakdown of Sales for 2012, 2020, and 2027
Table 193: Saudi Arabian Demand for Respiratory Diagnostics in
US$ Million by End-Use: 2020 to 2027
Table 194: Respiratory Diagnostics Market Review in Saudi
Arabia in US$ Million by End-Use: 2012-2019
Table 195: Saudi Arabian Respiratory Diagnostics Market Share
Breakdown by End-Use: 2012 VS 2020 VS 2027
UNITED ARAB EMIRATES
Table 196: Respiratory Diagnostics Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Disease for the Period 2020-2027
Table 197: United Arab Emirates Respiratory Diagnostics
Historic Market Analysis in US$ Million by Disease: 2012-2019
Table 198: Respiratory Diagnostics Market Share Distribution in
United Arab Emirates by Disease: 2012 VS 2020 VS 2027
Table 199: Respiratory Diagnostics Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by End-Use for the Period 2020-2027
Table 200: United Arab Emirates Respiratory Diagnostics
Historic Market Analysis in US$ Million by End-Use: 2012-2019
Table 201: Respiratory Diagnostics Market Share Distribution in
United Arab Emirates by End-Use: 2012 VS 2020 VS 2027
REST OF MIDDLE EAST
Table 202: Respiratory Diagnostics Market in Rest of Middle
East: Recent Past, Current and Future Analysis in US$ Million
by Disease for the Period 2020-2027
Table 203: Rest of Middle East Respiratory Diagnostics Historic
Market Analysis in US$ Million by Disease: 2012-2019
Table 204: Rest of Middle East Respiratory Diagnostics Market
Share Breakdown by Disease: 2012 VS 2020 VS 2027
Table 205: Respiratory Diagnostics Market in Rest of Middle
East: Annual Sales Estimates and Forecasts in US$ Million by
End-Use for the Period 2020-2027
Table 206: Rest of Middle East Respiratory Diagnostics Market
in Retrospect in US$ Million by End-Use: 2012-2019
Table 207: Respiratory Diagnostics Market Share Distribution in
Rest of Middle East by End-Use: 2012 VS 2020 VS 2027
AFRICA
Table 208: African Respiratory Diagnostics Market Estimates and
Projections in US$ Million by Disease: 2020 to 2027
Table 209: Respiratory Diagnostics Market in Africa by Disease:
A Historic Review in US$ Million for 2012-2019
Table 210: African Respiratory Diagnostics Market Share
Breakdown by Disease: 2012 VS 2020 VS 2027
Table 211: African Respiratory Diagnostics Latent Demand
Forecasts in US$ Million by End-Use: 2020 to 2027
Table 212: Respiratory Diagnostics Historic Demand Patterns in
Africa by End-Use in US$ Million for 2012-2019
Table 213: Respiratory Diagnostics Market Share Breakdown in
Africa by End-Use: 2012 VS 2020 VS 2027
IV. COMPETITION
Total Companies Profiled: 43
Read the full report: https://www.reportlinker.com/p05799512/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________